FDA Deputy Commissioner Friedman To Join Searle As Senior VP-Clinical
Executive Summary
FDA Deputy Commissioner for Operations Michael Friedman, MD, is leaving the agency to join Searle as senior VP-clinical affairs.
You may also be interested in...
Searle Oncology Given Boost By Pending P&U Merger, Antibody Deal
Searle will create a platform for new oncologics development through a research collaboration with Cambridge Antibody Technology.
Searle Oncology Given Boost By Pending P&U Merger, Antibody Deal
Searle will create a platform for new oncologics development through a research collaboration with Cambridge Antibody Technology.
FDA Senior Scientist Schwetz To Chair Deputy Commissioner Search Cmte.
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent deputy for the position recently vacated by Michael Friedman, MD.